References
- Dendrimers: A New Generation Carrier, (n.d.). https://www.omicsonline.org/open-access/dendrimers-a-new-generation-carrier-.pdf. (accessed Sep 24, 2022).
- Rastogi, V.; Yadav, P.; Bhattacharya, S. S.; Mishra, A. K.; Verma, N.; Verma, A.; Pandit, J. K. Carbon Nanotubes: An Emerging Drug Carrier for Targeting Cancer Cells. J. Drug Deliv. 2014, 2014, 670815–670823. DOI: 10.1155/2014/670815.
- Yadav, P.; Rastogi, V.; Kumar Mishra, A.; Verma, A. Carbon Nanotube: A Versatile Carrier for Various Biomedical Applications. Drug Deliv. Lett. 2014, 4, 156–169. DOI: 10.2174/2210303103666131220234222.
- Tripathy, S.; Das, M. K. Dendrimers and Their Applications as Novel Drug Delivery Carriers. J. Appl. Pharm. Sci. 2013, 3, 142–149. DOI: 10.7324/JAPS.2013.3924.
- Trollsås, M.; Hedrick, J. L. Dendrimer-like Star Polymers. J. Am. Chem. Soc. 1998, 120, 4644–4651. DOI: 10.1021/ja973678w.
- JeyapragashR, S. IJRPC. Dendrimer: A Novel Polymer, (n.d.), www.ijrpc.com. (accessed Sep 24, 2022).
- Bp. Kumar, Dendrimer: A Complete Drug Carrier, 1, 2011; pp. 25–39. www.ijprr.com (accessed Sep 24, 2022).
- Garg, T.; Onkar, S.; Saahil, A.; Murthy, R. S. R. Dendrimer- A Novel Scaffold for Drug Delivery, 2011, pp. 211–220. https://globalresearchonline.net/journalcontents/volume7issue2/Article-039.pdf (accessed Sep 24, 2022).
- Seema Pushkar, D. P.; Philip, A.; Pathak, K. Dendrimers: Nanotechnology derived novel polymers in drug delivery, Indian J. Pharm. Educ. Res. 2006, 40, 153–158. https://scholar.google.co.in/citations?view_op=view_citation&hl=en&user=HILfTOIAAAAJ&cstart=200&pagesize=100&sortby=pubdate&citation_for_view=HILfTOIAAAAJ:UeHWp8X0CEIC. (accessed Sep 24, 2022).
- Sakthivel, T.; Florence, A. T. Adsorption of Amphipathic Dendrons on Polystyrene Nanoparticles. Int. J. Pharm. 2003, 254, 23–26. DOI: 10.1016/S0378-5173(02)00671-3.
- C. J.; Hawker; J. M. J.; Fréchet. Preparation of Polymers with Controlled Molecular Architecture. A New Convergent Approach to Dendritic Macromolecules. J. Am. Chem. Soc. 1990, 112, 7638–7647. DOI: 10.1021/JA00177A027/ASSET/JA00177A027.FP.PNG_V03.
- Cheng, Y.; Xu, Z.; Ma, M.; Xu, T. Dendrimers as Drug Carriers: applications in Different Routes of Drug Administration. J. Pharm. Sci. 2008, 97, 123–143. DOI: 10.1002/JPS.21079.
- Bnv. Hari, P.; Kumar Gajula. Dendrimer: Globular Nanostructured Materials for Drug Delivery. Int. J. PharmTech Res. CODEN n.d, 4, 432–451.
- J. B. P.; Dhananjay, A.; Landge, S. S.; Shyale, Sagar, D.; Kadam Darshan, V.; Shah Yogesh; S. Katare. DENDRIMER: AN INNOVATIVE ACCEPTABLE APPROACH IN NOVEL DRUG DELIVERY SYSTEM - Pharmacophore, Pharmacophore. 2014. https://pharmacophorejournal.com/article/dendrimer-an-innovative-acceptable-approach-in-novel-drug-delivery-system (accessed Sep 24, 2022).
- Jain, N. K. Advances Controlled & Novel Drug Delivery. 2008. https://www.cbspd.co.in/advances-in-controlled-and-novel-drug-delivery-hb-2017 (accessed Sep 24, 2022).
- Tomalia, D. A. Birth of a New Macromolecular Architecture: Dendrimers as Quantized Building Blocks for Nanoscale Synthetic Polymer Chemistry. Prog. Polym. Sci. 2005, 30, 294–324. DOI: 10.1016/j.progpolymsci.2005.01.007.
- Kesharwani, S.; Kumar Jaiswal, P.; Kesharwani, R.; Kumar, V.; Patel, D. K. Dendrimer: A Novel Approach for Drug Delivery. J. Pharm. Sci. Innov. 2016, 5, 54–62. DOI: 10.7897/2277-4572.05212.
- Sato, K.; Anzai, J. I. Dendrimers in Layer-by-Layer Assemblies: Synthesis and Applications. Molecules 2013, 18, 8440–8460. DOI: 10.3390/molecules18078440.
- Svenson, S.; Tomalia, D. A. Dendrimers in Biomedical Applications—Reflections on the Field. Adv. Drug Deliv. Rev 2012, 64, 102–115. DOI: 10.1016/j.addr.2012.09.030.
- Kesharwani, P.; Jain, K.; Jain, N. K. Dendrimer as Nanocarrier for Drug Delivery. Prog. Polym. Sci. 2014, 39, 268–307. DOI: 10.1016/j.progpolymsci.2013.07.005.
- Wu, P.; Feldman, A. K.; Nugent, A. K.; Hawker, C. J.; Scheel, A.; Voit, B.; Pyun, J.; Fréchet, J. M. J.; Sharpless, K. B.; Fokin, V. V. Efficiency and Fidelity in a Click-Chemistry Route to Triazole Dendrimers by the Copper(i)-Catalyzed Ligation of Azides and Alkynes. Angew. Chem. Int. Ed. Engl. 2004, 43, 3928–3932. DOI: 10.1002/ANIE.200454078.
- Tomalia, D. A.; Baker, H.; Dewald, J.; Hall, M.; Kallos, G.; Martin, S.; Roeck, J.; Ryder, J.; Smith, P. A New Class of Polymers: Starburst-Dendritic Macromolecules, Polym. Polym. J. 1985, 17, 117–132. DOI: 10.1295/polymj.17.117.
- Brownlie, A.; Uchegbu, I. F.; Schätzlein, A. G. PEI-Based Vesicle-Polymer Hybrid Gene Delivery System with Improved Biocompatibility. Int. J. Pharm. 2004, 274, 41–52. DOI: 10.1016/j.ijpharm.2003.12.029.
- Liu, M.; Kono, K.; Fréchet, J. Water-Soluble Dendrimer-Poly(Ethylene Glycol) Starlike Conjugates as Potential Drug Carriers. J. Polym. Sci. Part A 1999, 37, 17. DOI: 10.1002/(SICI)1099-0518(19990901).
- Patel, V.; Patel, P.; Patel, J. V.; Patel, P. M. Dendrimer as a Versatile Platform for Biomedical Application: A Review. J. Indian Chem. Soc. 2022, 99, 100516. DOI: 10.1016/j.jics.2022.100516.
- Wagner, V.; Dullaart, A.; Bock, A. K.; Zweck, A. The Emerging Nanomedicine Landscape. Nat. Biotechnol. 2006, 24, 1211–1217. DOI: 10.1038/nbt1006-1211.
- Farokhzad, O. C.; Langer, R. Impact of Nanotechnology on Drug Delivery. ACS Nano 2009, 3, 16–20. DOI: 10.1021/NN900002M/ASSET/IMAGES/MEDIUM/NN-2009-00002M_0003.GIF.
- Yamashita, F.; Hashida, M. Pharmacokinetic Considerations for Targeted Drug Delivery. Adv. Drug Deliv. Rev. 2013, 65, 139–147. DOI: 10.1016/J.ADDR.2012.11.006.
- Khandare, J.; Calderón, M.; Dagia, N. M.; Haag, R. Multifunctional Dendritic Polymers in Nanomedicine: opportunities and Challenges. Chem. Soc. Rev. 2012, 41, 2824–2848. DOI: 10.1039/C1CS15242D.
- Svenson, S. Dendrimers as Versatile Platform in Drug Delivery Applications. Eur. J. Pharm. Biopharm. 2009, 71, 445–462. DOI: 10.1016/J.EJPB.2008.09.023.
- Michaud, G.; Visini, R.; Bergmann, M.; Salerno, G.; Bosco, R.; Gillon, E.; Richichi, B.; Nativi, C.; Imberty, A.; Stocker, A.; et al. Overcoming Antibiotic Resistance in Pseudomonas aeruginosa Biofilms Using Glycopeptide Dendrimers. Chem. Sci. 2016, 7, 166–182. DOI: 10.1039/C5SC03635F.
- Moiani, D.; Salvalaglio, M.; Cavallotti, C.; Bujacz, A.; Redzynia, I.; Bujacz, G.; Dinon, F.; Pengo, P.; Fassina, G. Structural Characterization of a Protein a Mimetic Peptide Dendrimer Bound to Human IgG. J. Phys. Chem. B 2009, 113, 16268–16275. DOI: 10.1021/JP909405B/ASSET/IMAGES/MEDIUM/JP-2009-09405B_0010.GIF.
- Kadam, R. U.; Bergmann, M.; Garg, D.; Gabrieli, G.; Stocker, A.; Darbre, T.; Reymond, J. L. Structure-Based Optimization of the Terminal Tripeptide in Glycopeptide Dendrimer Inhibitors of Pseudomonas aeruginosa Biofilms Targeting LecA. Chemistry 2013, 19, 17054–17063. DOI: 10.1002/CHEM.201302587.
- Baeriswyl, S.; Javor, S.; Stocker, A.; Darbre, T.; Reymond, J. L. X-Ray Crystal Structure of a Second-Generation Peptide Dendrimer in Complex with Pseudomonas aeruginosa Lectin LecB. Helv. Chim. Acta 2019, 102, e1900178. DOI: 10.1002/HLCA.201900178.
- Paulíková, G.; Houser, J.; Kašáková, M.; Oroszová, B.; Bertolotti, B.; Parkan, K.; Moravcová, J.; Wimmerová, M. Fucosylated Inhibitors of Recently Identified Bangle Lectin from Photorhabdus asymbiotica. Sci. Rep. 2019, 9, 12. DOI: 10.1038/s41598-019-51357-9.
- Johansson, E. M. V.; Crusz, S. A.; Kolomiets, E.; Buts, L.; Kadam, R. U.; Cacciarini, M.; Bartels, K. M.; Diggle, S. P.; Cámara, M.; Williams, P.; et al. Inhibition and Dispersion of Pseudomonas aeruginosa Biofilms by Glycopeptide Dendrimers Targeting the Fucose-Specific Lectin LecB. Chem. Biol. 2008, 15, 1249–1257. DOI: 10.1016/J.CHEMBIOL.2008.10.009.
- Ramaswamy, S.; Sleiman, M. H.; Masuyer, G.; Arbez-Gindre, C.; Micha-Screttas, M.; Calogeropoulou, T.; Steele, B. R.; Acharya, K. R. Structural Basis of Multivalent Galactose-Based Dendrimer Recognition by Human Galectin-7. FEBS J. 2015, 282, 372–387. DOI: 10.1111/FEBS.13140.
- Sun, L.; Lee, H.; Thibaut, H. J.; Lanko, K.; Rivero-Buceta, E.; Bator, C.; Martinez-Gualda, B.; Dallmeier, K.; Delang, L.; Leyssen, P.; et al. Viral Engagement with Host Receptors Blocked by a Novel Class of Tryptophan Dendrimers That Targets the 5-Fold-Axis of the enterovirus-A71 Capsid. PLoS Pathog. 2019, 15, e1007760. DOI: 10.1371/JOURNAL.PPAT.1007760.
- Visini, R.; Jin, X.; Bergmann, M.; Michaud, G.; Pertici, F.; Fu, O.; Pukin, A.; Branson, T. R.; Thies-Weesie, D. M. E.; Kemmink, J.; et al. Structural Insight into Multivalent Galactoside Binding to Pseudomonas aeruginosa Lectin LecA. ACS Chem. Biol. 2015, 10, 2455–2462. DOI: 10.1021/ACSCHEMBIO.5B00302.
- Teow, H. M.; Zhou, Z.; Najlah, M.; Yusof, S. R.; Abbott, N. J.; D'Emanuele, A. Delivery of Paclitaxel across Cellular Barriers Using a Dendrimer-Based Nanocarrier. Int. J. Pharm. 2013, 441, 701–711. DOI: 10.1016/J.IJPHARM.2012.10.024.
- Malik, N.; Wiwattanapatapee, R.; Klopsch, R.; Lorenz, K.; Frey, H.; Weener, J. W.; Meijer, E. W.; Paulus, W.; Duncan, R. Dendrimers: relationship between Structure and Biocompatibility in Vitro, and Preliminary Studies on the Biodistribution of 125I-Labelled Polyamidoamine Dendrimers in Vivo. J. Control. Release 2000, 65, 133–148. DOI: 10.1016/S0168-3659(99)00246-1.
- Jain, K.; Kesharwani, P.; Gupta, U.; Jain, N. K. Dendrimer Toxicity: Let’s Meet the Challenge. Int. J. Pharm. 2010, 394, 122–142. DOI: 10.1016/J.IJPHARM.2010.04.027.
- Cancino, J.; Paino, I. M. M.; Micocci, K. C.; Selistre-de-Araujo, H. S.; Zucolotto, V. In Vitro Nanotoxicity of Single-Walled Carbon Nanotube-Dendrimer Nanocomplexes against Murine Myoblast Cells. Toxicol. Lett. 2013, 219, 18–25. DOI: 10.1016/J.TOXLET.2013.02.009.
- Thiagarajan, G.; Sadekar, S.; Greish, K.; Ray, A.; Ghandehari, H. Evidence of Oral Translocation of Anionic G6.5 Dendrimers in Mice. Mol. Pharm. 2013, 10, 988–998. DOI: 10.1021/M.P300436C/SUPPL_FILE/MP300436C_SI_001.PDF.
- Thiagarajan, G.; Greish, K.; Ghandehari, H. Charge Affects the Oral Toxicity of Poly(Amidoamine) Dendrimers. Eur. J. Pharm. Biopharm. 2013, 84, 330–334. DOI: 10.1016/J.EJPB.2013.01.019.
- Janaszewska, A.; Ciolkowski, M.; Wróbel, D.; Petersen, J. F.; Ficker, M.; Christensen, J. B.; Bryszewska, M.; Klajnert, B. Modified PAMAM Dendrimer with 4-Carbomethoxypyrrolidone Surface Groups Reveals Negligible Toxicity against Three Rodent Cell-Lines. Nanomedicine 2013, 9, 461–464. DOI: 10.1016/J.NANO.2013.01.010.
- Nishikawa, M.; Takakura, Y.; Hashida, M. Pharmacokinetic Evaluation of Polymeric Carriers. Adv. Drug Deliv. Rev 1996, 21, 135–155. DOI: 10.1016/S0169-409X(96)00403-6.
- Kaminskas, L. M.; Boyd, B. J.; Porter, C. J. H. Dendrimer Pharmacokinetics: The Effect of Size, Structure and Surface Characteristics on ADME Properties. Nanomedicine (Lond) 2011, 6, 1063–1084. DOI: 10.2217/NNM.11.67.
- Srinageshwar, B.; Peruzzaro, S.; Andrews, M.; Johnson, K.; Hietpas, A.; Clark, B.; McGuire, C.; Petersen, E.; Kippe, J.; Stewart, A.; et al. PAMAM Dendrimers Cross the Blood-Brain Barrier When Administered through the Carotid Artery in C57BL/6J Mice. Int. J. Mol. Sci. 2017, 18, 628. DOI: 10.3390/ijms18030628.
- Boyd, B. J.; Kaminskas, L. M.; Karellas, P.; Krippner, G.; Lessene, R.; Porter, C. J. H. Cationic poly-L-Lysine Dendrimers: Pharmacokinetics, Biodistribution, and Evidence for Metabolism and Bioresorption after Intravenous Administration to Rats. Mol. Pharm. 2006, 3, 614–627. DOI: 10.1021/MP060032E/SUPPL_FILE/MP060032ESI20060627_024931.PDF.
- Nigavekar, S. S.; Sung, L. Y.; Llanes, M.; El-Jawahri, A.; Lawrence, T. S.; Becker, C. W.; Balogh, L.; Khan, M. K.; Dendrimer Nanoparticle, 3H. Organ/Tumor Distribution. Pharm. Res. 2004, 21, 476–483. DOI: 10.1023/B:PHAM.0000019302.26097.cc.
- Ke, W.; Zhao, Y.; Huang, R.; Jiang, C.; Pei, Y. Enhanced Oral Bioavailability of Doxorubicin in a Dendrimer Drug Delivery System. J. Pharm. Sci. 2008, 97, 2208–2216. DOI: 10.1002/JPS.21155.
- Kitchens, K. M.; Foraker, A. B.; Kolhatkar, R. B.; Swaan, P. W.; Ghandehari, H. Endocytosis and Interaction of Poly (Amidoamine) Dendrimers with Caco-2 Cells. Pharm. Res. 2007, 24, 2138–2145. DOI: 10.1007/S11095-007-9415-0.
- Najlah, M.; Freeman, S.; Attwood, D.; D’Emanuele, A. Synthesis and Assessment of First-Generation Polyamidoamine Dendrimer Prodrugs to Enhance the Cellular Permeability of P-gp Substrates. Bioconjug. Chem. 2007, 18, 937–946. DOI: 10.1021/BC060325Q.
- D’Emanuele, A.; Jevprasesphant, R.; Penny, J.; Attwood, D. The Use of a Dendrimer-Propranolol Prodrug to Bypass Efflux Transporters and Enhance Oral Bioavailability. J. Control. Release 2004, 95, 447–453. DOI: 10.1016/j.jconrel.2003.12.006.
- Najlah, M.; Freeman, S.; Attwood, D.; D’Emanuele, A. In Vitro Evaluation of Dendrimer Prodrugs for Oral Drug Delivery. Int. J. Pharm. 2007, 336, 183–190. DOI: 10.1016/J.IJPHARM.2006.11.047.
- Cheng, Y.; Man, N.; Xu, T.; Fu, R.; Wang, X.; Wang, X.; Wen, L. Transdermal Delivery of Nonsteroidal anti-Inflammatory Drugs Mediated by Polyamidoamine (PAMAM) Dendrimers. J. Pharm. Sci. 2007, 96, 595–602. DOI: 10.1002/JPS.20745.
- Chauhan, A. S.; Jain, N. K.; Diwan, P. V.; Khopade, A. J. Solubility Enhancement of Indomethacin with Poly(Amidoamine) Dendrimers and Targeting to Inflammatory Regions of Arthritic Rats. J. Drug. Target. 2004, 12, 575–583. DOI: 10.1080/10611860400010655.
- Chauhan, A. S.; Sridevi, S.; Chalasani, K. B.; Jain, A. K.; Jain, S. K.; Jain, N. K.; Diwan, P. V. Dendrimer-Mediated Transdermal Delivery: Enhanced Bioavailability of Indomethacin. J. Control. Release 2003, 90, 335–343. DOI: 10.1016/S0168-3659(03)00200-1.
- V. V. K.; Venuganti.; O. P.; Perumal. Poly(Amidoamine) Dendrimers as Skin Penetration Enhancers: Influence of Charge, Generation, and Concentration. J. Pharm. Sci. 2009, 98, 2345–2356. DOI: 10.1002/JPS.21603.
- Llamazares, C.; Del Olmo, N. S.; Ortega, P.; Gómez, R.; Soliveri, J.; De La Mata, F. J.; García-Gallego, S.; Copa-Patiño, J. L. Antibacterial Effect of Carbosilane Metallodendrimers in Planktonic Cells of Gram-Positive and Gram-Negative Bacteria and Staphylococcus aureus Biofilm. Biomolecules 2019, 9, 405. DOI: 10.3390/biom9090405.
- Wrońska, N.; Majoral, J. P.; Appelhans, D.; Bryszewska, M.; Lisowska, K. Synergistic Effects of Anionic/Cationic Dendrimers and Levofloxacin on Antibacterial Activities. Molecules 2019, 24, 2894. DOI: 10.3390/molecules24162894.
- Liu, Y.; Tee, J.; Chiu, G. Dendrimers in Oral Drug Delivery Application: current Explorations, Toxicity Issues and Strategies for Improvement. Curr. Pharm. Des. 2015, 21, 2629–2642. DOI: 10.2174/1381612821666150416102058.
- Huang, X.; Wu, Z.; Gao, W.; Chen, Q.; Yu, B. Polyamidoamine Dendrimers as Potential Drug Carriers for Enhanced Aqueous Solubility and Oral Bioavailability of Silybin. Drug Dev. Ind. Pharm. 2011, 37, 419–427. DOI: 10.3109/03639045.2010.518150.
- Zeng, Z.; Qi, D.; Yang, L.; Liu, J.; Tang, Y.; Chen, H.; Feng, X. Stimuli-Responsive Self-Assembled Dendrimers for Oral Protein Delivery. J. Control. Release 2019, 315, 206–213. DOI: 10.1016/J.JCONREL.2019.10.049.
- Vandamme, T. F.; Brobeck, L. Poly(Amidoamine) Dendrimers as Ophthalmic Vehicles for Ocular Delivery of Pilocarpine Nitrate and Tropicamide. J. Control. Release 2005, 102, 23–38. DOI: 10.1016/J.JCONREL.2004.09.015.
- Yao, W.; Sun, K.; Mu, H.; Liang, N.; Liu, Y.; Yao, C.; Liang, R.; Wang, A. Preparation and Characterization of Puerarin-Dendrimer Complexes as an Ocular Drug Delivery System. Drug Dev. Ind. Pharm. 2010, 36, 1027–1035. DOI: 10.3109/03639041003610799.
- Nasr, M.; Najlah, M.; D'Emanuele, A.; Elhissi, A. PAMAM Dendrimers as Aerosol Drug Nanocarriers for Pulmonary Delivery via Nebulization. Int. J. Pharm. 2014, 461, 242–250. DOI: 10.1016/J.IJPHARM.2013.11.023.
- Surekha, B.; Kommana, N. S.; Dubey, S. K.; Kumar, A. V. P.; Shukla, R.; Kesharwani, P. PAMAM Dendrimer as a Talented Multifunctional Biomimetic Nanocarrier for Cancer Diagnosis and Therapy. Colloid. Surf. B Biointerfaces 2021, 204, 111837. DOI: 10.1016/J.COLSURFB.2021.111837.
- Marcinkowska, M.; Stanczyk, M.; Janaszewska, A.; Sobierajska, E.; Chworos, A.; Klajnert-Maculewicz, B. Multicomponent Conjugates of Anticancer Drugs and Monoclonal Antibody with PAMAM Dendrimers to Increase Efficacy of HER-2 Positive Breast Cancer Therapy. Pharm. Res. 2019, 36, 154. DOI: 10.1007/s11095-019-2683-7.
- Kesharwani, P.; Chadar, R.; Shukla, R.; Jain, G. K.; Aggarwal, G.; Abourehab, M. A. S.; Sahebkar, A. Recent Advances in Multifunctional Dendrimer-Based Nanoprobes for Breast Cancer Theranostics. J. Biomater. Sci. Polym. Ed. 2022, 33, 2433–2471. DOI: 10.1080/09205063.2022.2103627.
- Oddone, N.; Lecot, N.; Fernández, M.; Rodriguez-Haralambides, A.; Cabral, P.; Cerecetto, H.; Benech, J. C. In Vitro and in Vivo Uptake Studies of PAMAM G4.5 Dendrimers in Breast Cancer. J. Nanobiotechnol. 2016, 14, 45. DOI: 10.1186/s12951-016-0197-6.
- Krasheninina, O. A.; Apartsin, E. K.; Fuentes, E.; Szulc, A.; Ionov, M.; Venyaminova, A. G.; Shcharbin, D.; de la Mata, F. J.; Bryszewska, M.; Gómez, R. Complexes of Pro-Apoptotic siRNAs and Carbosilane Dendrimers: Formation and Effect on Cancer Cells. Pharmaceutics 2019, 11, 25. DOI: 10.3390/pharmaceutics11010025.
- Vincent, L.; Varet, J.; Pille, J. Y.; Bompais, H.; Opolon, P.; Maksimenko, A.; Malvy, C.; Mirshahi, M.; Lu, H.; Vannier, J. P.; et al. Efficacy of Dendrimer-Mediated Angiostatin and TIMP-2 Gene Delivery on Inhibition of Tumor Growth and Angiogenesis: In Vitro and in Vivo Studies. Int. J. Cancer 2003, 105, 419–429. DOI: 10.1002/IJC.11105.
- Liu, J.; Liu, J.; Chu, L.; Wang, Y.; Duan, Y.; Feng, L.; Yang, C.; Wang, L.; Kong, D. Novel Peptide-Dendrimer Conjugates as Drug Carriers for Targeting Nonsmall Cell Lung Cancer. Int J Nanomedicine 2010, 6, 59–69. DOI: 10.2147/IJN.S14601.
- Sunoqrot, S.; Liu, Y.; Kim, D. H.; Hong, S. In Vitro Evaluation of Dendrimer-Polymer Hybrid Nanoparticles on Their Controlled Cellular Targeting Kinetics. Mol. Pharm. 2013, 10, 2157–2166. DOI: 10.1021/M.P300560N/SUPPL_FILE/MP300560N_SI_001.PDF.
- Kaur, A.; Jain, K.; Mehra, N. K.; Jain, N. K. Development and Characterization of Surface Engineered PPI Dendrimers for Targeted Drug Delivery. Artif. Cells Nanomed. Biotechnol. 2017, 45, 414–425. DOI: 10.3109/21691401.2016.1160912.
- Bhatt, H.; Kiran Rompicharla, S. V.; Ghosh, B.; Biswas, S. α-Tocopherol Succinate-Anchored PEGylated Poly(Amidoamine) Dendrimer for the Delivery of Paclitaxel: Assessment of in Vitro and in Vivo Therapeutic Efficacy. Mol. Pharm. 2019, 16, 1541–1554. DOI: 10.1021/ACS.MOLPHARMACEUT.8B01232/SUPPL_FILE/M.P8B01232_SI_001.PDF.
- Mbatha, L. S.; Singh, M. Starburst Poly(Amidoamine) Dendrimer Grafted Gold Nanoparticles as a Scaffold for Folic Acid-Targeted Plasmid DNA Delivery in Vitro. J. Nanosci. Nanotechnol. 2019, 19, 1959–1970. DOI: 10.1166/JNN.2019.15798.
- Bae, Y.; Thuy, L. T.; Lee, Y. H.; Ko, K. S.; Han, J.; Choi, J. S. Polyplexes of Functional PAMAM Dendrimer/Apoptin Gene Induce Apoptosis of Human Primary Glioma Cells in Vitro. Polymers (Basel) 2019, 11, 296. DOI: 10.3390/polym11020296.
- Seixas, N.; Ravanello, B.; Morgan, I.; Kaluđerović, G.; Wessjohann, L. Chlorambucil Conjugated Ugi Dendrimers with PAMAM-NH2 Core and Evaluation of Their Anticancer Activity. Pharmaceutics 2019, 11, 59. DOI: 10.3390/pharmaceutics11020059.
- Bosman, A. W.; Janssen, H. M.; Meijer, E. W. About Dendrimers: Structure, Physical Properties, and Applications. Chem. Rev. 1999, 99, 1665–1688. DOI: 10.1021/CR970069Y.
- Langereis, S.; Dirksen, A.; Hackeng, T. M.; Van Genderen, M. H. P.; Meijer, E. W. Dendrimers and Magnetic Resonance Imaging. New J. Chem. 2007, 31, 1152–1160. DOI: 10.1039/b616960k.
- Huang, C. H.; Nwe, K.; Al Zaki, A.; Brechbiel, M. W.; Tsourkas, A. Biodegradable Polydisulfide Dendrimer Nanoclusters as MRI Contrast Agents. ACS Nano. 2012, 6, 9416–9424. DOI: 10.1021/NN304160P/SUPPL_FILE/NN304160P_SI_001.PDF.
- Zhu, J.; Gale, E. M.; Atanasova, I.; Rietz, T. A.; Caravan, P. Hexameric Mn(II) Dendrimer as MRI Contrast Agent. Chemistry 2014, 20, 14507–14513. DOI: 10.1002/CHEM.201403883.
- Esmaeili, E.; Khalili, M.; Sohi, A. N.; Hosseinzadeh, S.; Taheri, B.; Soleimani, M. Dendrimer Functionalized Magnetic Nanoparticles as a Promising Platform for Localized Hyperthermia and Magnetic Resonance Imaging Diagnosis. J. Cell Physiol. 2019, 234, 12615–12624. DOI: 10.1002/JCP.27849.
- Dufès, C.; Uchegbu, I. F.; Schätzlein, A. G. Dendrimers in Gene Delivery. Adv. Drug Deliv. Rev. 2005, 57, 2177–2202. DOI: 10.1016/J.ADDR.2005.09.017.
- Shcharbin, D. G.; Klajnert, B.; Bryszewska, M. Dendrimers in Gene Transfection. Biochemistry (Mosc). 2009, 74, 1070–1079. DOI: 10.1134/S0006297909100022.
- Haensler, J.; Szoka, F. C. Polyamidoamine Cascade Polymers Mediate Efficient Transfection of Cells in Culture. Bioconjug. Chem. 1993, 4, 372–379. DOI: 10.1021/BC00023A012.
- Kukowska-Latallo, J. F.; Bielinska, A. U.; Johnson, J.; Spindle, R.; Tomalia, D. A.; Baker, J. R. Efficient Transfer of Genetic Material into Mammalian Cells Using Starburst Polyamidoamine Dendrimers. Proc. Natl. Acad. Sci. USA 1996, 93, 4897–4902. DOI: 10.1073/PNAS.93.10.4897.
- Thuy, L. T.; Choi, M.; Lee, M.; Choi, J. S. Preparation and Characterization of Polyamidoamine Dendrimers Conjugated with Cholesteryl-Dipeptide as Gene Carriers in HeLa Cells. J. Biomater. Sci. Polym. Ed. 2022, 33, 976–994. DOI: 10.1080/09205063.2022.2030657.
- F.; Liu, X.; Wang, L. Yuzhou; M.; Ren, P.; He, L.; Wang, J. Xu, S.; Yang.; P.; Ji. Dendrimer-Modified Gelatin Methacrylate Hydrogels Carrying Adipose-Derived Stromal/Stem Cells Promote Cartilage Regeneration. Stem. Cell. Res. Ther. 2022, 13, 1–15. DOI: 10.1186/S13287-022-02705-6/FIGURES/6.
- Duan, X.; Sheardown, H. Dendrimer Crosslinked Collagen as a Corneal Tissue Engineering Scaffold: mechanical Properties and Corneal Epithelial Cell Interactions. Biomaterials 2006, 27, 4608–4617. DOI: 10.1016/J.BIOMATERIALS.2006.04.022.
- Chowdhury, S.; Toth, I.; Stephenson, R. J. Dendrimers in Vaccine Delivery: Recent Progress and Advances. Biomaterials 2022, 280, 121303. DOI: 10.1016/J.BIOMATERIALS.2021.121303.
- Wang, Y.; Gong, N.; Ma, C.; Zhang, Y.; Tan, H.; Qing, G.; Zhang, J.; Wang, Y.; Wang, J.; Chen, S.; et al. An Amphiphilic Dendrimer as a Light-Activable Immunological Adjuvant for in Situ Cancer Vaccination. Nat. Commun. 2021, 12, 16. DOI: 10.1038/s41467-021-25197-z.
- Cañas-Arranz, R.; de León, P.; Forner, M.; Defaus, S.; Bustos, M. J.; Torres, E.; Andreu, D.; Blanco, E.; Sobrino, F. Immunogenicity of a Dendrimer B2T Peptide Harboring a T-Cell Epitope from FMDV Non-Structural Protein 3D. Front. Vet. Sci. 2020, 7, 498. DOI: 10.3389/FVETS.2020.00498/BIBTEX.
- Anwaier, G.; Chen, C.; Cao, Y.; Qi, R. A Review of Molecular Imaging of Atherosclerosis and the Potential Application of Dendrimer in Imaging of Plaque. Int. J. Nanomed. 2017, 12, 7681–7693. DOI: 10.2147/IJN.S142385.
- Ye, K.; Qin, J.; Peng, Z.; Yang, X.; Huang, L.; Yuan, F.; Peng, C.; Jiang, M.; Lu, X. Polyethylene Glycol-Modified Dendrimer-Entrapped Gold Nanoparticles Enhance CT Imaging of Blood Pool in Atherosclerotic Mice. Nanoscale. Res. Lett. 2014, 9, 519–529. DOI: 10.1186/1556-276X-9-529/FIGURES/9.
- Klajnert, B.; Cortijo-Arellano, M.; Cladera, J.; Bryszewska, M. Influence of Dendrimer’s Structure on Its Activity against Amyloid Fibril Formation. Biochem. Biophys. Res. Commun. 2006, 345, 21–28. DOI: 10.1016/J.BBRC.2006.04.041.
- Klajnert, B.; Wasiak, T.; Ionov, M.; Fernandez-Villamarin, M.; Sousa-Herves, A.; Correa, J.; Riguera, R.; Fernandez-Megia, E. Dendrimers Reduce Toxicity of Aβ 1-28 Peptide during Aggregation and Accelerate Fibril Formation. Nanomedicine 2012, 8, 1372–1378. DOI: 10.1016/J.NANO.2012.03.005.
- Klementieva, O.; Benseny-Cases, N.; Gella, A.; Appelhans, D.; Voit, B.; Cladera, J. Dense Shell Glycodendrimers as Potential Nontoxic anti-Amyloidogenic Agents in Alzheimer’s Disease. Amyloid-Dendrimer Aggregates Morphology and Cell Toxicity. Biomacromolecules 2011, 12, 3903–3909. DOI: 10.1021/BM2008636.
- Wasiak, T.; Marcinkowska, M.; Pieszynski, I.; Zablocka, M.; Caminade, A. M.; Majoral, J. P.; Klajnert-Maculewicz, B. Cationic Phosphorus Dendrimers and Therapy for Alzheimer’s Disease. New J. Chem. 2015, 39, 4852–4859. DOI: 10.1039/C5NJ00309A.
- Shi, X.; Majoros, I. J.; Patri, A. K.; Bi, X.; Islam, M. T.; Desai, A.; Ganser, T. R.; Baker, J. R. Molecular Heterogeneity Analysis of Poly(Amidoamine) Dendrimer-Based Mono- and Multifunctional Nanodevices by Capillary Electrophoresis. Analyst 2006, 131, 374–381. DOI: 10.1039/B515624F.
- Al-Azzawi, S.; Masheta, D.; Guildford, A. L.; Phillips, G.; Santin, M. Dendrimeric Poly(Epsilon-Lysine) Delivery Systems for the Enhanced Permeability of Flurbiprofen across the Blood-Brain Barrier in Alzheimer’s Disease. Int. J. Mol. Sci. 2018, 19, 3224. DOI: 10.3390/ijms19103224.
- Singh, A.; Ujjwal, R. R.; Naqvi, S.; Verma, R. K.; Tiwari, S.; Kesharwani, P.; Shukla, R. Formulation Development of Tocopherol Polyethylene Glycol Nanoengineered Polyamidoamine Dendrimer for Neuroprotection and Treatment of Alzheimer Disease. J. Drug Target. 2022, 30, 777–791. DOI: 10.1080/1061186X.2022.2063297.
- Singh, A.; Mhaske, A.; Shukla, R. Fabrication of TPGS-Grafted Polyamidoamine Dendrimer for Enhanced Piperine Brain Delivery and Pharmacokinetics. AAPS PharmSciTech 2022, 23, 1–14. DOI: 10.1208/s12249-022-02393-8.
- Shukla, R.; Sethi, A.; Handa, M.; Mohan, M.; Tripathi, P. K.; Kesharwani, P. Dendrimer-Based Drug Delivery Systems for Tuberculosis Treatment, Undefined. Nanotechnology Based Approaches for Tuberculosis Treatment; Elsevier Science: Amsterdam, Netherlands, 2020; pp. 163–174. 10.1016/B978-0-12-819811-7.00010-2
- Vijayaraj Kumar, P.; Agashe, H.; Dutta, T.; Jain, N. PEGylated Dendritic Architecture for Development of a Prolonged Drug Delivery System for an Antitubercular Drug. Curr. Drug Deliv. 2007, 4, 11–19. DOI: 10.2174/156720107779314794.
- Bellini, R. G.; Guimarães, A. P.; Pacheco, M. A. C.; Dias, D. M.; Furtado, V. R.; De Alencastro, R. B.; Horta, B. A. C. Association of the anti-Tuberculosis Drug Rifampicin with a PAMAM Dendrimer. J. Mol. Graph. Model. 2015, 60, 34–42. DOI: 10.1016/J.JMGM.2015.05.012.
- US20180251574A1 - Fucan-dendrimer Based Compounds and Complexes - Google Patents, n.d. https://patents.google.com/patent/US20180251574A1/en. (accessed Sep 24, 2022).
- US11344627B2 - Dendrimer-exosome Hybrid Nanoparticles as a Delivery Platform - Google Patents, n.d. https://patents.google.com/patent/US11344627B2/en?q=Dendrimer-exosome+hybrid+nanoparticles+delivery+platform&oq=Dendrimer-exosome+hybrid+nanoparticles+as+a+delivery+platform (accessed Sep 25, 2022).
- Therapeutic Dendrimers - Dimensions, n.d. https://app.dimensions.ai/details/patent/US-10314920-B2 (accessed Sep 24, 2022).
- Kong, H.; Wong, A. T.; Ma, J.; Peng, L.; Lo, K. W.; Limited, V. US10421968B2 - Amphiphilic Dendrimers Complexed with siRNA for Treatment of Cancer - Google Patents, (n.d.). https://patents.google.com/patent/US10421968B2/en (accessed Sep 24, 2022).
- WO2018160759 Zwitterionic Dendritic Amphiphiles, Zwitterionic Dendrimers, Zwitterionic Telodendrimers, Nanocarriers Comprising Same, and Methods of Making and Using Same, (n.d.). https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2018160759 (accessed Sep 24, 2022).
- US10690675B2 - Methods for Enriching Glycopeptides for Global Analysis of Glycoproteins - Google Patents, (n.d.). https://patents.google.com/patent/US10690675B2/en (accessed Sep 24, 2022).
- US20170313828A1 - In Situ-forming of Dendrimer Hydrogels Using Michael-addition Reaction - Google Patents, (n.d.). https://patents.google.com/patent/US20170313828A1/en?q=In+situ-forming+of+dendrimer+hydrogels+using+michael-addition+reaction.&oq=In+situ-forming+of+dendrimer+hydrogels+using+michael-addition+reaction (accessed Sep 24, 2022).
- US20190142953A1 - Dendrimer-Drug Conjugates, Hydrogel Compositions, and Methods - Google Patents, (n.d.). https://patents.google.com/patent/US20190142953A1/en?q=Dendrimer-drug+conjugates%2C+hydrogel+compositions%2C+and+methods&oq=Dendrimer-drug+conjugates%2C+hydrogel+compositions%2C+and+methods. (accessed Sept 24, 2022).
- US20210236539A1 - Method of Prophylaxis of Zika Virus Infection - Google Patents, (n.d.). https://patents.google.com/patent/US20210236539A1/en?q=Method+of+prophylaxis+of+zika+virus+infection&oq=Method+of+prophylaxis+of+zika+virus+infection&page=2 (accessed Sep 24, 2022).
- US10604759B2 - Targeting Glioblastoma Stem Cells through the TLX-TET3 Axis - Google Patents, (n.d.). https://patents.google.com/patent/US10604759B2/en?q=Targeting+glioblastoma+stem+cells+the+TLX-TET3+axis&oq=Targeting+glioblastoma+stem+cells+through+the+TLX-TET3+axis (accessed Sep 24, 2022).
- US10172951B2 - Dendrimer Based Nanodevices for Therapeutic and Imaging Purposes - Google Patents, (n.d.). https://patents.google.com/patent/US10172951B2/en?q=Dendrimer+based+nanodevices+for+therapeutic+and+imaging+purposes&oq=Dendrimer+based+nanodevices+for+therapeutic+and+imaging+purposes (accessed Sep 24, 2022).
- HUE039734T2 - Dendrimer Like Amino Amides Possessing Sodium Channel Blocker Activity for the Treatment of Dry Eye and Other Mucosal Diseases - Google Patents, (n.d.). https://patents.google.com/patent/HUE039734T2/en?q=Dendrimer+amino+amides+possessing+sodium+channel+blocker+activity+for+the+treatment+of+dry+eye+and+other+mucosal+diseases&. oq = Dendrimer + like + amino + amides + possessing + sodium + channel + blocker + activity + for + the + treatment + of + dry + eye + and + other + mucosal + diseases (accessed Sep 24, 2022).
- US10172779B2 - Copolymer Having Carbosiloxane Dendrimer Structure and Composition and Cosmetic Containing the Same - Google Patents, (n.d.). https://patents.google.com/patent/US10172779B2/en?q=Copolymer+having+carbosiloxane+dendrimer+structure+and+composition+and+cosmetic+containing+the+same&oq=Copolymer+having+carbosiloxane+dendrimer+structure+and+composition+and+cosmetic+containing+the+same (accessed Sep 24, 2022).
- US10918720B2 - Selective Dendrimer Delivery to Brain Tumors - Google Patents, (n.d.). https://patents.google.com/patent/US10918720B2/en?q=Selective+dendrimer+delivery+to+brain+tumors&oq=Selective+dendrimer+delivery+to+brain+tumors (accessed Sep 24, 2022).
- EP3086760B1 - Solid Composition Comprising a Vinyl Polymer Bearing a Carbosiloxane Dendrimer Unit, Volatile Hydrocarbon-based Oils and Solid Fatty Alcohol, and Treatment Process - Google Patents, (n.d.). https://patents.google.com/patent/EP3086760B1/en?q=Solid+composition+comprising+vinyl+polymer+bearing+carbosiloxane+dendrimer+unit&oq=Solid+composition+comprising+a+vinyl+polymer+bearing+a+carbosiloxane+dendrimer+unit (accessed Sep 25, 2022).
- CA2946422C - Dendrimer Compositions and their Use in Treatment of Diseases of the Eye - Google Patents, (n.d.). https://patents.google.com/patent/CA2946422C/en (accessed Sep 25, 2022).
- EP2341915B1 - Phosphorylated Dendrimers as Antiinflammatory Drugs - Google Patents, (n.d.). https://patents.google.com/patent/EP2341915B1/en?q=Phosphorylated+dendrimers+antiinflammatory+drugs&oq=Phosphorylated+dendrimers+as+antiinflammatory+drugs (accessed Sep 25, 2022).
- EP3122763B1 - Antimicrobial Peptide Dendrimers - Google Patents, (n.d.). https://patents.google.com/patent/EP3122763B1/en?q=Antimicrobial+peptide+dendrimers&oq=Antimicrobial+peptide+dendrimers (accessed Sep 25, 2022).
- US20190092837 Prion Protein-dendrimer Conjugates for Use in Treatment of Alzheimer Disease, (n.d.). https://patentscope.wipo.int/search/en/detail.jsf?docId=US239825863&docAn=16300214 (accessed Sep 25, 2022).
- US10898594B2 - PAMAM Dendrimer Based CEST Imaging Agents and Uses Thereof - Google Patents, (n.d.). https://patents.google.com/patent/US10898594B2/en?q=PAMAM+dendrimer+based+CEST+imaging+agents+and+uses&oq=PAMAM+dendrimer+based+CEST+imaging+agents+and+uses+thereof. (accessed Sep 25, 2022).
- US6395257B1 - Dendrimer Precursor Dyes for Imaging - Google Patents, (n.d.). https://patents.google.com/patent/US6395257B1/en (accessed Sep 25, 2022).
- Patel, V.; Rajani, C.; Paul, D.; Borisa, P.; Rajpoot, K.; Youngren-Ortiz, S. R.; Tekade, R. K. Dendrimers as Novel Drug-Delivery System and Its Applications. Drug Delivery Systems; Elsevier Science: Amsterdam, Netherlands, 2020; pp. 333–392. 10.1016/B978-0-12-814487-9.00008-9.
- Caminade, A. M. Dendrimers, an Emerging Opportunity in Personalized Medicine? J. Pers. Med. 2022, 12, 1334. DOI: 10.3390/jpm12081334.
- A Study to Evaluate the Safety, Pharmacokinetics and Biodistribution of an Imaging Agent, 18F-OP-801 (18F Hydroxyl Dendrimer) in Patients With Amyotrophic Lateral Sclerosis (ALS) and Healthy Volunteers (HV) - Full Text View - ClinicalTrials.gov, (n.d.). https://clinicaltrials.gov/ct2/show/NCT05395624?term=Dendrimer&draw=2&rank=1 (accessed Dec 4, 2022).
- A Study to Evaluate OP-101 (Dendrimer N-acetyl-cysteine) in Severe Coronavirus Disease 2019 (COVID-19) Patients - Full Text View - ClinicalTrials.gov, (n.d.). https://clinicaltrials.gov/ct2/show/NCT04458298?term=Dendrimer&draw=2&rank=3 (accessed Dec 4, 2022).
- A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of D-4517.2 After Subcutaneous Administration in Subjects With Neovascular (Wet) Age-Related Macular Degeneration (AMD) or Subjects With Diabetic Macular Edema (DME) - Full Text View - ClinicalTrials.gov, (n.d.). https://clinicaltrials.gov/ct2/show/NCT05387837?term=Dendrimer&draw=2&rank=4 (accessed Dec 4, 2022).
- Clinical Trials Register, (n.d.). https://www.clinicaltrialsregister.eu/ctr-search/trial/2019-001318-40/GB (accessed Dec 4, 2022).
- Evaluation of Safety & Efficacy of MIR 19 ® Inhalation Solution in Patients With Moderate COVID-19 - Full Text View - ClinicalTrials.gov, (n.d.). https://clinicaltrials.gov/ct2/show/NCT05184127?cond=NCT05184127&draw=2&rank=1 (accessed Dec 4, 2022).
- Clinical Trials Register, (n.d.). https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000694-39/CZ (accessed Dec 4, 2022).
- A Phase I/II Study of AZD0466 as Monotherapy or in Combination With Anticancer Agents in Advanced Non-Hodgkin Lymphoma - Full Text View - ClinicalTrials.gov, (n.d.). https://clinicaltrials.gov/ct2/show/NCT05205161?cond=NCT05205161&draw=2&rank=1 (accessed Dec 4, 2022).